A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Gordon Anglesea was found guilty on four counts of indecent assault that took place between 1982 and 1987.
Largely dry and fairly cloudy this afternoon with a few scattered showers and some sunny spells.
European Commission President said an EU-Canada free trade deal would help end Canadian visa restrictions for Romanians and Bulgarians.